AU2001211986B2 - Composition and method for stable injectable liquids - Google Patents

Composition and method for stable injectable liquids Download PDF

Info

Publication number
AU2001211986B2
AU2001211986B2 AU2001211986A AU2001211986A AU2001211986B2 AU 2001211986 B2 AU2001211986 B2 AU 2001211986B2 AU 2001211986 A AU2001211986 A AU 2001211986A AU 2001211986 A AU2001211986 A AU 2001211986A AU 2001211986 B2 AU2001211986 B2 AU 2001211986B2
Authority
AU
Australia
Prior art keywords
particles
glass
composition according
stable
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001211986A
Other languages
English (en)
Other versions
AU2001211986A1 (en
Inventor
Arcadio Garcia De Castro
Bruce Joseph Roser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Biostability Ltd
Original Assignee
Cambridge Biostability Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd filed Critical Cambridge Biostability Ltd
Publication of AU2001211986A1 publication Critical patent/AU2001211986A1/en
Priority to AU2005203369A priority Critical patent/AU2005203369B2/en
Application granted granted Critical
Publication of AU2001211986B2 publication Critical patent/AU2001211986B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001211986A 2000-10-13 2000-10-13 Composition and method for stable injectable liquids Ceased AU2001211986B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2005203369A AU2005203369B2 (en) 2000-10-13 2005-07-29 Pharmaceutical liquid suspensions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (fr) 2000-10-13 2000-10-13 Composition et procede pour liquides injectables stables

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005203369A Division AU2005203369B2 (en) 2000-10-13 2005-07-29 Pharmaceutical liquid suspensions

Publications (2)

Publication Number Publication Date
AU2001211986A1 AU2001211986A1 (en) 2002-07-04
AU2001211986B2 true AU2001211986B2 (en) 2007-04-26

Family

ID=21741883

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001211986A Ceased AU2001211986B2 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids
AU1198601A Pending AU1198601A (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU1198601A Pending AU1198601A (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Country Status (12)

Country Link
EP (1) EP1328255A1 (fr)
JP (1) JP2004513093A (fr)
KR (1) KR20030096224A (fr)
CN (1) CN100339066C (fr)
AU (2) AU2001211986B2 (fr)
CA (2) CA2424656C (fr)
ES (1) ES2337252T3 (fr)
MX (1) MXPA03003236A (fr)
NO (1) NO20031706D0 (fr)
PL (1) PL360052A1 (fr)
PT (1) PT1452171E (fr)
WO (1) WO2002032402A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502825A1 (fr) * 2002-10-22 2004-05-06 Dainippon Pharmaceutical Co., Ltd. Composition stabilisee
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
JP2007532619A (ja) 2004-04-13 2007-11-15 ケンブリッジ バイオスタビリティ リミテッド 懸濁したガラス粒子を含有する液体
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
MX2010007632A (es) * 2008-01-18 2010-08-03 Asahi Kasei Pharma Corp Composicion farmaceutica estable.
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (fr) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension de particules comprenant un médicament
WO2011007327A2 (fr) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension pour usage thérapeutique et dispositif d'administration de ladite suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
EP3124275A4 (fr) 2014-03-24 2018-03-14 Seiko Epson Corporation Dispositif d'impression de bande et systeme d'impression de bande
CN106102724A (zh) * 2014-03-27 2016-11-09 诺华股份有限公司 用于吸入活性药物成分的经喷雾干燥的水包油包固体分散系

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (fr) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
References cited in WO 98/32402 *

Also Published As

Publication number Publication date
PT1452171E (pt) 2010-03-08
EP1328255A1 (fr) 2003-07-23
CN1527699A (zh) 2004-09-08
NO20031706L (no) 2003-04-11
AU1198601A (en) 2002-04-29
CA2424656A1 (fr) 2002-04-25
NO20031706D0 (no) 2003-04-11
CA2689856C (fr) 2013-09-24
WO2002032402A1 (fr) 2002-04-25
ES2337252T3 (es) 2010-04-22
MXPA03003236A (es) 2004-12-03
CA2424656C (fr) 2010-03-23
PL360052A1 (en) 2004-09-06
KR20030096224A (ko) 2003-12-24
JP2004513093A (ja) 2004-04-30
CN100339066C (zh) 2007-09-26
CA2689856A1 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
US6190701B1 (en) Composition and method for stable injectable liquids
AU2001211986B2 (en) Composition and method for stable injectable liquids
AU2001211986A1 (en) Composition and method for stable injectable liquids
Parumasivam et al. Dry powder inhalable formulations for anti-tubercular therapy
EP1750668B1 (fr) Liquides contenant des particules de verre en suspension
EA001873B1 (ru) Стабильная частица в жидких композициях
US20110045079A1 (en) Dry powders of cellular material
TWI260988B (en) Lipophilic-coated microparticles containing a protein drug or antigen and formulation comprising same
WO2000000215A1 (fr) Systemes administration de particules et procedes d'utilisation
KR20030020294A (ko) 분말 조성물
CA2438108C (fr) Composition pharmaceutique et methode d'injection a liberation controlee connexe
AU2005203369B2 (en) Pharmaceutical liquid suspensions
EP1452171B1 (fr) Suspensions liquides pharmaceutiques
AU760537C (en) Particulate delivery systems and methods of use
JP4027881B2 (ja) 安定注射液用の組成物および方法
JP4382706B2 (ja) 医薬液体懸濁物
RU2259817C2 (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
KR100743442B1 (ko) 약제적 액체 현탁액
NZ525026A (en) A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
NZ538681A (en) A pharmaceutical composition comprising active biological ingredient carried by particles that form a stable suspension in a liquid indefinitely
AU2004204392A1 (en) Pharmaceutical aerosol composition
KR950005867B1 (ko) 흡입제
CN100594937C (zh) 稳定的注射液组合物和方法
JP2003527413A (ja) 粘膜表面へ投与するための医薬組成物

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: DELETE THE CO-INVENTOR MAKI, JAMES.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired